ANTI-IL-6-ANTIKÖRPERFORMULIERUNG

Patent europeic · EP3962942 · En vigur

Inscripziun en il register

Numer da publicaziun
EP3962942
Numer da la dumonda
EP20728590
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
30-04-2020
Publitgà
09-03-2022
Concedì
22-10-2025
La protecziun finescha il pli tard
29-04-2040
Proxima taxa annuala scadenta
30-04-2027
Classas IPC
C07K 16/24 (2006.01)
A61K 39/395 (2006.01)
A61K 47/18 (2017.01)
A61K 47/26 (2006.01)
Prioritad
US 201962841662 P 01.05.2019
EP 19181345 19.06.2019
Dumonda PCT
PCT/US2020/030865 30.04.2020
Publicaziun PCT
WO2020/223565 05.11.2020
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 02-09-2026

    Midada

    Published in Swissreg on 02.09.2026

  2. 01-05-2026

    Next annual fee due on

    Next annual fee due on
    30.04.2026 → 30.04.2027

    Published in Swissreg on 01.05.2026

  3. 22-10-2025

    Concedì

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 22.10.2025

Partidas

Possessur

Novo Nordisk A/S

Novo Allé, 2880 Bagsværd, DK

Inventur

ZHU, Gaozhong

2880 Bagsværd, DK

SHAHROKH, Zahra

2880 Bagsværd, DK

MELVILLE, Mark

2880 Bagsværd, DK

DEVALARAJA, Madhav, N.

2880 Bagsværd, DK

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.